---
title: "Dean Kamen resigns from BETA's Board; leaves Compensation Committee"
description: "BETA Technologies has accepted Dean Kamen's resignation from its Board of Directors and Compensation Committee, effective January 18, 2026. Kamen, a longstanding board member, resigned to avoid potent"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/276325347.md"
published_at: "2026-02-19T11:13:00.000Z"
---

# Dean Kamen resigns from BETA's Board; leaves Compensation Committee

> BETA Technologies has accepted Dean Kamen's resignation from its Board of Directors and Compensation Committee, effective January 18, 2026. Kamen, a longstanding board member, resigned to avoid potential distractions as the company focuses on its strategic priorities. Replacement information has not been disclosed.

**BETA accepted Dean Kamen's resignation from its Board of Directors and Compensation Committee, effective January 18, 2026.**

Individual

Dean Kamen

Role

Member, Board of Directors; Member, Compensation Committee

Type of Change

Resigned

Effective Date

January 18, 2026

Reason

To avoid potential distractions as the Company focuses on executing its strategic priorities

Replacement Info

Not disclosed

Background Details

Longstanding board member who provided guidance, leadership, investment, and contributed to advancing innovation, science, and engineering

Board/Committee Role Changes

Departure from Compensation Committee

Original SEC Filing: BETA Technologies, Inc. \[ BETA \] - 8-K - Feb. 19, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BETA.US - Beta Tech](https://longbridge.com/en/quote/BETA.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| BETA 科技董事會審查將公司治理和增長故事置於嚴格審查之下 | BETA Technologies 面臨審查，因為董事會成員 Dean Kamen 在與 Jeffrey Epstein 的關聯下請假。獨立調查正在進行中，這引發了人們對公司治理的擔憂，恰逢公司首次公開募股（IPO）之後。這一情況突顯了董事 | [Link](https://longbridge.com/en/news/276007978.md) |
| Beta 股票上漲 25%，這要歸功於亞馬遜 | 亞馬遜擁有 Beta Technologies 超過 5% 的股份。亞馬遜在 2021 年通過其氣候承諾基金進行了投資 | [Link](https://longbridge.com/en/news/275607560.md) |
| Beta Bionics 將在 TD Cowen 第 46 屆年度醫療保健會議上進行演講 | Beta Bionics, Inc. 將於 2026 年 3 月 4 日上午 10:30（東部時間）在 TD Cowen 第 46 屆年度醫療保健會議上進行演講。公司將在 “投資者 - 活動與演示” 部分提供現場音頻網絡廣播，並在活動結束後 | [Link](https://longbridge.com/en/news/276377169.md) |
| Beta Bionics (BBNX) 的收入增長速度超過了持續的虧損，並對樂觀的市場敍述構成了考驗 | Beta Bionics (BBNX) 報告了 2025 財年第四季度的收入為 3210 萬美元，淨虧損為 1350 萬美元，全年總收入為 1 億 0030 萬美元，虧損為 7320 萬美元。儘管收入增長了 53.9%，但對持續虧損和高運營 | [Link](https://longbridge.com/en/news/276294945.md) |
| 專家觀點：從 7 位分析師的視角看 Beta Bionics | Beta Bionics（納斯達克代碼：BBNX）被 7 位分析師分析，評級呈現出從看漲到看跌的混合狀態。12 個月的平均目標價為 27.29 美元，較之前的 32.17 美元有所下降。最近的動態包括 Baird、Stifel 和 Trui | [Link](https://longbridge.com/en/news/276237262.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.